Clinical trial
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
NCT07299097 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 2, 2025
- Completion date
- September 30, 2026
- Enrollment
- 402 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
narcolepsy type 1, narcolepsy type 2